Anti-CENP-B positivity was not significantly associated with mortality, cancer, or interstitial lung disease.<h4>Conclusion</h4>Anti-CENP-B positivity in pSjD may identify a different baseline serological and clinical profile, characterized by relatively milder immunologic abnormalities and lower disease activity. This evidence concerns the gene CENPB and cancer.